Publications database

Filter by

(-) Remove Publication type: Implementation reports filter Publication type: Implementation reports
(-) Remove Keywords: synthetic drugs filter Keywords: synthetic drugs
(-) Remove Keywords: cyclopropylfentanyl filter Keywords: cyclopropylfentanyl
(-) Remove Keywords: CUMYL-4CN-BINACA filter Keywords: CUMYL-4CN-BINACA

Publication date

August 10, 2018 (1) Apply August 10, 2018 filter

Series / Type

Implementation reports (1) Apply Implementation reports filter

Language

English (1) Apply English filter

Main subject

NPS (1) Apply NPS filter

Keywords

(-) Remove CUMYL-4CN-BINACA filter CUMYL-4CN-BINACA
(-) Remove cyclopropylfentanyl filter cyclopropylfentanyl
(-) Remove synthetic drugs filter synthetic drugs
4F-iBF (1) Apply 4F-iBF filter
5F-MDMB-PINACA (1) Apply 5F-MDMB-PINACA filter
AB-CHMINACA (1) Apply AB-CHMINACA filter
ADB-CHMINACA (1) Apply ADB-CHMINACA filter
carfentanil (1) Apply carfentanil filter
furanylfentanyl (1) Apply furanylfentanyl filter
methoxyacetylfentanyl (1) Apply methoxyacetylfentanyl filter
NPS (1) Apply NPS filter
pharmacology (1) Apply pharmacology filter
THF-F (1) Apply THF-F filter

Sort by

Displaying 1 - 1 of 1

Implementation reports

EMCDDA–Europol 2017 Annual Report on the implementation of Council Decision 2005/387/JHA

August 2018

This report presents the key activities performed by the EMCDDA and Europol in 2017 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, including new psychoactive substances notified in 2017...

.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>